Top-News
Biotechnologie Großbritannien

Immunocore Holdings Plc. Aktie

Aktie
WKN:  A2QNWU ISIN:  US45258D1054 US-Symbol:  IMCR
29,80 €
+0,40 €
+1,36%
14.01.25
Handeln Depot/Watchlist
Aktienanzahl *
49,44 Mio.
Marktkapitalisierung *
1,38 Mrd. €
Streubesitz
0,28%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 18.01.2024

Immunocore Holdings Plc. News

04.03.24 - wallstreetONLINE Redaktion
BB Biotech: 4,23 Prozent Ausschüttung, positive Aussichten und attraktiv bewertet
BB Biotech-​Aktien haben im Zuge der steigenden Zinsen an Wert verloren. Aktuell deutet vieles auf eine Marktstabilisierung hin. Im März 2024 schüttet das Unternehmen abermals ...
21.10.23 - GlobeNewswire
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial
Data published in New England Journal of Medicine and presented as a late breaking abstract in mini oral session at ESMO Congress 2023
18.04.23 - PR Newswire
Grey Wolf Therapeutics Reports Promising Preclinical Data from Research Collaboration with Immunocore in Oral Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023
Grey Wolf Therapeutics Reports Promising Preclinical Data from Research Collaboration with Immunocore in Oral Presentation at the American Association for Cancer Research ...
09.09.22 - GlobeNewswire
Immunocore presents promising initial Phase 1 data for first off-the-shelf TCR therapy targeting PRAME at the ESMO 2022 Congress
Immunocore presents promising initial Phase 1 data for first off-​the-shelf TCR therapy targeting PRAME at the ESMO 2022 Congress
23.05.22 - PR Newswire
Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand
Medison Pharma Announces Extension of Multi-​territorial Agreement with Immunocore and Expansion into Australia and New Zealand PR Newswire
23.05.22 - PR Newswire
Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand
Medison Pharma Announces Extension of Multi-​territorial Agreement with Immunocore and Expansion into Australia and New Zealand PR Newswire
15.04.22 - The Motley Fool
2 taufrische Biotechs, die für das nächste Jahrzehnt gehalten werden sollten
In 3 Sätzen Legend Biotech will seine kürzlich zugelassene CAR-​T-Zelltherapie in frühere Behandlungslinien einführen. Immunocore brachte Anfang dieses Jahres die allererste ...
27.05.21 - GlobeNewswire
Immunocore to present at upcoming investor conferences
P RESS RELEASE
12.05.21 - GlobeNewswire
Immunocore Reports First Quarter 2021 Financial Results
PRESS RELEASE
12.04.21 - GlobeNewswire
Immunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual Meeting
PRESS RELEASE

Newssuche

Videos

newspaper
13.01.25 -2,03%
Technical Trading: Cotton Zukauf Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »